Fact CheckerSign in

NCT06874764Enrolling by invitation

Effect of Training With Wireless Lightning Reaction Systems on Cognitive Functions in Individuals With Multiple Sclerosis

Effects of Agility and Cognitive Training With Reaction System on Cognitive Functions and Walking in Individuals With Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 9 Jan 2026

Brief summary (registry, in English)

When the literature is examined, balance disorders, walking disorders and cognitive problems are frequently observed in Multiple Sclerosis(MS) patients. Using technologically supported equipment such as reaction systems, cognitive function measurements have been successfully performed in the elderly, and improvements in reaction times have been detected in athletes when used for training purposes. The primary aim of the study is to provide improvement in agility and cognitive functions in patients using a technology-supported reaction device. In addition, it aims to improve balance function assessed with static posturography and gait parameters assessed with gait analysis by increasing sensory input and shortening reaction time. As a result of the agility and cognitive training performed, we aim to provide improvement in MS-related quality of life and decrease in disability.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
40 (estimated)
First submitted
3 Mar 2025
Start date
Jan 2026
Primary completion date
May 2026
Lead sponsor
Ege University
NCT number
NCT06874764

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From Jan 2026 to the primary completion date, May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of antipsychotic and psychostimulant drugs
  • Drug and alcohol addiction

Other illness

  • Presence of additional accompanying neurological diseases
  • No chronic systemic disease preventing exercise

Other

  • Regular exercise in the last 6 months
  • Having an MS attack in the last month
  • Having an MS attack during the study period
  • Use of dalfampridine
  • Pregnancy, breastfeeding
  • Patients who cannot reach the targeted exercise level

Who the study is looking for

  • Being between the ages of 18-55
  • Having a definite MS diagnosis according to the 2017 McDonald criteria.
  • EDSS score of 4 or below
  • Being able to communicate (speaking and understanding Turkish, no speech disorders)

Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ege University Sport Medicine Clinic
Coordinator of this site? Confirm its status
IzmirTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.